Memorial Sloan Kettering Cancer CenterLow Disease Burden Improved Durability of CAR T-Cell Therapy in B-ALLCancer NetworkAlthough most adults with relapsed B-cell acute lymphoblastic leukemia (B-ALL) experienced complete remission after treatment with … Continue reading
Memorial Sloan Kettering Cancer CenterLow Disease Burden Improved Durability of CAR T-Cell Therapy in B-ALLCancer NetworkAlthough most adults with relapsed B-cell acute lymphoblastic leukemia (B-ALL) experienced complete remission after treatment with … Continue reading
SelectScience |
Advantages of Automated Workflow Miniaturization for Synthetic Biology
SelectScience At the Labcyte Genomics Symposium, Dr. D’Amore discussed how miniaturization of synthetic biology has reduced working volumes from 1.5 ml to <0.5 ml and from 96-well plates to microliter reactions in 1536-well plates. The challenge now is to reduce and … |
SelectScience |
Advantages of Automated Workflow Miniaturization for Synthetic Biology
SelectScience At the Labcyte Genomics Symposium, Dr. D’Amore discussed how miniaturization of synthetic biology has reduced working volumes from 1.5 ml to <0.5 ml and from 96-well plates to microliter reactions in 1536-well plates. The challenge now is to reduce and … |
UCLA Newsroom |
Alumni Weekend Teach-Ins 2017: stem cell research and standing up to “alternative facts”
UC Santa Cruz (press release) Alumni Weekend Teach-Ins 2017: stem cell research and standing up to “alternative facts”. At the popular Teach-Ins lecture series during UC Santa Cruz’s Alumni Weekend celebrations, returning Slugs hear thought-provoking presentations by outstanding … Artificial thymus developed at UCLA can produce cancer-fighting T cells from blood stem cellsUCLA Newsroom Mayur Abhaya’s Rs 125-crore stem cell company secures future of likes of Aishwarya Rai’s daughterYourStory.com The risks of unproven stem cell treatmentsRadio New Zealand Medgadget (blog) –Multiple Sclerosis News Today –MilTech all 13 news articles » |
UCLA Newsroom |
Artificial thymus developed at UCLA can produce cancer-fighting T cells from blood stem cells
UCLA Newsroom UCLA researchers have created a new system to produce human T cells, the white blood cells that fight against disease-causing intruders in the body. The system could be utilized to engineer T cells to find and attack cancer cells, which means it could … Mayur Abhaya’s Rs 125-crore stem cell company secures future of …YourStory.com The risks of unproven stem cell treatmentsRadio New Zealand First-in-Human Stem Cell Clinical Trial for Spinal Injury ExpandsNewswise (press release) |
|
First-in-Human Stem Cell Clinical Trial for Spinal Injury Expands
Newswise (press release) Newswise — Launched in 2014 with the initial phase I study, this first-in-human clinical trial is evaluating the safety of neural stem cell transplantation in patients with chronic spinal cord injuries. The trial is a collaboration between researchers … |
Medical Xpress |
Stem cell innovation regrows rotator cuffs
Medical Xpress A team of researchers from UConn Health has found a way to regenerate rotator cuff tendons after they’re torn, using a nano-textured fabric seeded with stem cells. Credit: Getty Images/University of Connecticut. Every time you throw a ball, swing a … |